Dr. Alessia Fornoni is a Professor of Medicine, Molecular and Cellular Pharmacology, and Biochemistry at the University of Miami Miller School of Medicine. She serves as the Director and Chair of the Peggy and Harold Katz Drug Discovery Center. Dr. Fornoni gained experience in drug development at Hoffmann-La Roche in Basel and is the founding scientist of several start-up companies. Her research is supported by grants from the NIH, industry, and private foundations.
She has received numerous prestigious awards, including membership in the American Society of Clinical Investigation (ASCI, 2017), the Association of American Physicians (AAP, 2021), and the Florida Academy of Science, Engineering, and Medicine (ASEMFL, 2023). Dr. Fornoni serves on the editorial boards of the Journal of Clinical Investigation and Kidney International and was the Deputy Editor of JASN in 2024. She began her term as the At-Large Councilor for the ASN Council in January 2025.
A recipient of multiple mentorship awards, her trainees hold leadership roles in various academic institutions worldwide. As Co-Director of the MD/PhD MSTP program, the CTSI K12 program, and Director of an NIH-funded summer school in Nephrology, Dr. Fornoni demonstrates a strong commitment to mentoring students and junior faculty toward successful academic careers.
Through her pioneering work on insulin signaling, cholesterol metabolism, and sphingolipid-related pathways, Dr. Fornoni has uncovered novel pathogenetic mechanisms and therapeutic approaches for glomerular disorders, which have successfully progressed to ongoing clinical trials.
Day 2 - Monday April 15, 2024
Time |
Session |
|
3 p.m.
4 p.m.
|
MichelleRheault
Chairperson
rheau002@umn.eduUniversity of MinnesotaUnited States
-
Predicting the Risks of Kidney Failure and Death in Adults With Moderate-to-severe Chronic Kidney Disease (KDpredict)
PietroRavani
Free Communication
pravani@ucalgary.caUniversity of CalgaryCanada
-
Plasma Exchange in ANCA Associated Vasculitis GN: Update After Pexivas
Wladimir MietekSzpirt
Speaker
wladimir.mietek.szpirt.01@regionh.dkRigshospitalet, University of Copenhagen, Dept. of Nephrology, Denmark, Senior Research ConsultantDenmark
-
EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY: INTERIM RESULTS FROM THE PHASE 3 APPLAUSE-IgAN STUDY
DanaRizk
Free Communication
drizk@uabmc.eduUniversity of Alabama at BirminghamUnited States
-
SPARSENTAN VS IRBESARTAN IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IgAN): SUBGROUP ANALYSES OF 2-YEAR RESULTS FROM THE PIVOTAL PHASE 3 PROTECT TRIAL
JonathanBarratt
Free Communication
University of Leicester, Leicester, UKUnited Kingdom
-
PREGNANCY AMONG WOMEN ON CHRONIC DIALYSIS : THE FRENCH COHORT
CécileCouchoud
Free Communication
cecile.couchoud@biomedecine.frREIN registry, Agence de la biomédecine, FranceFrance
Hall A
|
Day 3 - Tuesday April 16, 2024
Time |
Session |
|
11 a.m.
12:15 p.m.
|
|
Pre-Congress - Saturday April 13, 2024
Time |
Session |
|
4:30 p.m.
6 p.m.
|
-
ISN President's Address
-
Tribute to Stewart Cameron
-
Welcome by WHO Director of Non-Communicable Diseases Dr Bente Mikkelsen
-
Welcome by Dr. Marina Papaginovic, SAN President; Dr. Guillermo Rosa Diez, WCN Local Organising Group Chair; and Dr. Jorge Rico, SLANH President and WCN Local Organizing Group co-Chair
GuillermoRosa Diez
Speaker
guillermo.rosadiez@hospitalitaliano.org.arHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of NephrologyArgentina
JorgeRico
Speaker
jorgericof@yahoo.comColombia
-
Welcome by Minister of Health for Buenos Aries Dr Fern
-
Welcome by SPWG Chair Alessia Fornoni
-
The Origin of the Universe
DanielDe Florian
Speaker
deflo@unsam.edu.arUniversidad Nacional de San MartinArgentina
-
Acceptance Speech: Hamburger Award
AdeeraLevin
Speaker
University of British Columbia and Providence Health CareCanada
Hall A
|